Back
Fiserv Vs. NovoCure Industry Stock Comparison
Buy
68
FI
Fiserv
Last Price:
$206.47
Seasonality Move:
7.18%
Sell
47
NVCR
NovoCure
Last Price:
$27.01
Seasonality Move:
5.69%
Sell
47
NovoCure (NVCR)
is a Sell
Is NovoCure a Buy, Sell or Hold?
-
NVCR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
FI Stock Price Chart
NVCR Stock Price Chart
FI Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.05 | Buy |
Relative Strength Index (14 RSI): | 50.08 | Buy |
Chaikin Money Flow: | -533559 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (203.13 - 208.35) | Buy |
Bollinger Bands (100): | (183.2 - 212.76) | Buy |
NVCR Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.19 | Sell |
Relative Strength Index (14 RSI): | 46.86 | Sell |
Chaikin Money Flow: | 104159 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (27.15 - 31.15) | Sell |
Bollinger Bands (100): | (15.12 - 27.36) | Buy |
FI Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 206.25 | Buy |
20-day SMA: | 206.29 | Buy |
50-day SMA: | 209.35 | Sell |
200-day SMA: | 176.26 | Buy |
8-day EMA: | 206.86 | Sell |
20-day EMA: | 206.41 | Buy |
50-day EMA: | 204.96 | Buy |
200-day EMA: | 181.43 | Buy |
NVCR Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 26.62 | Buy |
20-day SMA: | 28.61 | Sell |
50-day SMA: | 25.8 | Buy |
200-day SMA: | 19.68 | Buy |
8-day EMA: | 27.03 | Sell |
20-day EMA: | 27.72 | Sell |
50-day EMA: | 25.96 | Buy |
200-day EMA: | 21.9 | Buy |
Fiserv Earnings Growth & FI Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.43 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.44 per share, and an increase next year of $1.73 per share.
NovoCure Earnings Growth & NVCR Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.10 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.40 per share, and a decrease next year of $0.03 per share.
Fiserv Technical Analysis
Jan 8 | Jan 10 | Jan 13 | Jan 14 | Jan 15 | Jan 16 | Jan 17 | Jan 21 | Jan 22 | Jan 23 | |
---|---|---|---|---|---|---|---|---|---|---|
Jan | ||||||||||
08 | 10 | 13 | 14 | 15 | 16 | 17 | 21 | 22 | 23 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
NovoCure Technical Analysis
Jan 8 | Jan 10 | Jan 13 | Jan 14 | Jan 15 | Jan 16 | Jan 17 | Jan 21 | Jan 22 | Jan 23 | |
---|---|---|---|---|---|---|---|---|---|---|
Jan | ||||||||||
08 | 10 | 13 | 14 | 15 | 16 | 17 | 21 | 22 | 23 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |